Do analysts recommend HIT or KINS?

Health In Tech presently has a consensus price target of $4.00, suggesting a potential upside of 284.62%. Given Health In Tech's stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than Kingstone Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Kingstone Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer RDZN or HIT?

Health In Tech has a consensus target price of $4.00, suggesting a potential upside of 284.62%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than Roadzen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roadzen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is RDZN or HIT more profitable?

Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -30.61%. Company Net Margins Return on Equity Return on Assets Roadzen -30.61% N/A -40.70% Health In Tech N/A N/A N/A

Health In Tech (HIT) Competitors

$1.04 +0.07 (+7.23%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$1.03 -0.01 (-1.35%)

As of 06/26/2026 06:49 PM Eastern

Compare

HIT vs. OSG, KINS, JRVR, SLQT, and RDZN

Should you buy Health In Tech stock or one of its competitors? MarketBeat compares Health In Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health In Tech include Octave Specialty Group (OSG), Kingstone Companies (KINS), James River Group (JRVR), SelectQuote (SLQT), and Roadzen (RDZN). These companies are all part of the "insurance" industry.

How does Health In Tech compare to Octave Specialty Group?

Octave Specialty Group (NYSE:OSG) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

Octave Specialty Group has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.93, meaning that its stock price is 193% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than Octave Specialty Group. Health In Tech is trading at a lower price-to-earnings ratio than Octave Specialty Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Octave Specialty Group	$251.22M	1.19	-$261.69M	-$4.86	N/A
Health In Tech	$34.08M	2.00	-$1.31M	-$0.02	N/A

Octave Specialty Group presently has a consensus target price of $15.00, indicating a potential upside of 125.46%. Health In Tech has a consensus target price of $4.00, indicating a potential upside of 284.62%. Given Health In Tech's higher possible upside, analysts plainly believe Health In Tech is more favorable than Octave Specialty Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Octave Specialty Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Health In Tech had 1 more articles in the media than Octave Specialty Group. MarketBeat recorded 1 mentions for Health In Tech and 0 mentions for Octave Specialty Group. Health In Tech's average media sentiment score of 1.87 beat Octave Specialty Group's score of 0.00 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
Octave Specialty Group	Neutral
Health In Tech	Very Positive

80.9% of Octave Specialty Group shares are owned by institutional investors. 7.2% of Octave Specialty Group shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Health In Tech has a net margin of 0.00% compared to Octave Specialty Group's net margin of -75.91%. Health In Tech's return on equity of 0.00% beat Octave Specialty Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Octave Specialty Group	-75.91%	-0.55%	-0.13%
Health In Tech	N/A	N/A	N/A

Summary

Health In Tech beats Octave Specialty Group on 11 of the 15 factors compared between the two stocks.

How does Health In Tech compare to Kingstone Companies?

Health In Tech (NASDAQ:HIT) and Kingstone Companies (NASDAQ:KINS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

Health In Tech has a beta of 2.93, meaning that its stock price is 193% more volatile than the broader market. Comparatively, Kingstone Companies has a beta of 0.46, meaning that its stock price is 54% less volatile than the broader market.

Kingstone Companies has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.00	-$1.31M	-$0.02	N/A
Kingstone Companies	$214.87M	1.23	$40.77M	$2.15	8.46

Kingstone Companies has a net margin of 13.86% compared to Health In Tech's net margin of 0.00%. Kingstone Companies' return on equity of 28.63% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Kingstone Companies	13.86%	28.63%	7.23%

14.9% of Kingstone Companies shares are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 5.1% of Kingstone Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Kingstone Companies had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Kingstone Companies and 1 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.87 beat Kingstone Companies' score of 0.72 indicating that Health In Tech is being referred to more favorably in the media.

Company	Overall Sentiment
Health In Tech	Very Positive
Kingstone Companies	Positive

Health In Tech presently has a consensus price target of $4.00, suggesting a potential upside of 284.62%. Given Health In Tech's stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than Kingstone Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Kingstone Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Kingstone Companies beats Health In Tech on 9 of the 16 factors compared between the two stocks.

How does Health In Tech compare to James River Group?

James River Group (NASDAQ:JRVR) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

James River Group has a beta of -0.16, indicating that its share price is 116% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.93, indicating that its share price is 193% more volatile than the broader market.

James River Group has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than James River Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
James River Group	$687.61M	0.30	$47.43M	$0.34	13.06
Health In Tech	$34.08M	2.00	-$1.31M	-$0.02	N/A

James River Group presently has a consensus price target of $6.44, suggesting a potential upside of 44.99%. Health In Tech has a consensus price target of $4.00, suggesting a potential upside of 284.62%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than James River Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
James River Group	2 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.71
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

James River Group has a net margin of 4.34% compared to Health In Tech's net margin of 0.00%. James River Group's return on equity of 10.79% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
James River Group	4.34%	10.79%	1.13%
Health In Tech	N/A	N/A	N/A

In the previous week, James River Group and James River Group both had 1 articles in the media. James River Group's average media sentiment score of 1.89 beat Health In Tech's score of 1.87 indicating that James River Group is being referred to more favorably in the media.

Company	Overall Sentiment
James River Group	Very Positive
Health In Tech	Very Positive

95.2% of James River Group shares are held by institutional investors. 33.8% of James River Group shares are held by company insiders. Comparatively, 77.7% of Health In Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

James River Group beats Health In Tech on 9 of the 15 factors compared between the two stocks.

How does Health In Tech compare to SelectQuote?

SelectQuote (NYSE:SLQT) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

SelectQuote has a net margin of 5.60% compared to Health In Tech's net margin of 0.00%. SelectQuote's return on equity of 20.49% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SelectQuote	5.60%	20.49%	5.58%
Health In Tech	N/A	N/A	N/A

In the previous week, SelectQuote and SelectQuote both had 1 articles in the media. Health In Tech's average media sentiment score of 1.87 beat SelectQuote's score of 0.59 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
SelectQuote	Positive
Health In Tech	Very Positive

SelectQuote has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SelectQuote	$1.53B	0.10	$47.58M	$0.09	9.50
Health In Tech	$34.08M	2.00	-$1.31M	-$0.02	N/A

SelectQuote has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.93, suggesting that its stock price is 193% more volatile than the broader market.

34.6% of SelectQuote shares are owned by institutional investors. 13.1% of SelectQuote shares are owned by company insiders. Comparatively, 77.7% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

SelectQuote presently has a consensus target price of $3.00, indicating a potential upside of 250.88%. Health In Tech has a consensus target price of $4.00, indicating a potential upside of 284.62%. Given Health In Tech's higher probable upside, analysts plainly believe Health In Tech is more favorable than SelectQuote.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SelectQuote	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	2.75
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

SelectQuote beats Health In Tech on 10 of the 15 factors compared between the two stocks.

How does Health In Tech compare to Roadzen?

Roadzen (NASDAQ:RDZN) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -30.61%.

Company	Net Margins	Return on Equity	Return on Assets
Roadzen	-30.61%	N/A	-40.70%
Health In Tech	N/A	N/A	N/A

In the previous week, Roadzen had 3 more articles in the media than Health In Tech. MarketBeat recorded 4 mentions for Roadzen and 1 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.87 beat Roadzen's score of 0.50 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
Roadzen	Positive
Health In Tech	Very Positive

Roadzen has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.93, meaning that its stock price is 193% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than Roadzen. Health In Tech is trading at a lower price-to-earnings ratio than Roadzen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Roadzen	$44.30M	2.88	-$72.87M	-$0.20	N/A
Health In Tech	$34.08M	2.00	-$1.31M	-$0.02	N/A

24.7% of Roadzen shares are held by institutional investors. 29.5% of Roadzen shares are held by insiders. Comparatively, 77.7% of Health In Tech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Health In Tech has a consensus target price of $4.00, suggesting a potential upside of 284.62%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than Roadzen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Roadzen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Health In Tech beats Roadzen on 10 of the 15 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Insurance Agents, Brokers & Service Industry	Finance Sector	NASDAQ Exchange
Market Cap	$68.15M	$1.30B	$13.85B	$12.22B
Dividend Yield	N/A	N/A	5.72%	6.13%
P/E Ratio	-52.00	55.28	20.48	24.18
Price / Sales	2.00	9.31	134.87	113.35
Price / Cash	N/A	61.87	19.26	54.37
Price / Book	N/A	0.55	2.26	6.36
Net Income	-$1.31M	$17.47M	$1.14B	$337.99M
7 Day Performance	-3.70%	1.42%	0.90%	0.10%
1 Month Performance	11.27%	0.20%	1.32%	-0.11%
1 Year Performance	25.73%	6.34%	15.36%	27.61%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	2.3089 of 5 stars	$1.04 +7.2%	$4.00 +284.6%	+29.9%	$68.15M	$34.08M	N/A	79	Positive News Gap Down
OSG Octave Specialty Group	4.1271 of 5 stars	$5.74 -0.3%	$15.00 +161.3%	N/A	$259.28M	$251.22M	N/A	130	Gap Up
KINS Kingstone Companies	3.9221 of 5 stars	$16.25 flat	N/A	+17.4%	$235.38M	$214.87M	7.56	90
JRVR James River Group	4.7917 of 5 stars	$3.95 flat	$6.44 +63.0%	-22.6%	$182.64M	$687.61M	11.62	640	Positive News High Trading Volume
SLQT SelectQuote	4.287 of 5 stars	$0.98 -0.4%	$3.00 +204.9%	-63.1%	$174.30M	$1.53B	10.93	4,269

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. OSG, KINS, JRVR, SLQT, and RDZN

How does Health In Tech compare to Octave Specialty Group?

Summary

How does Health In Tech compare to Kingstone Companies?

Summary

How does Health In Tech compare to James River Group?

Summary

How does Health In Tech compare to SelectQuote?

Summary

How does Health In Tech compare to Roadzen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. OSG, KINS, JRVR, SLQT, and RDZN

How does Health In Tech compare to Octave Specialty Group?

Which has more risk & volatility, OSG or HIT?

Which has stronger valuation & earnings, OSG or HIT?

Do analysts prefer OSG or HIT?

Does the media refer more to OSG or HIT?

Do insiders & institutionals believe in OSG or HIT?

Is OSG or HIT more profitable?

Summary

How does Health In Tech compare to Kingstone Companies?

Which has more risk & volatility, HIT or KINS?

Which has preferable valuation and earnings, HIT or KINS?

Is HIT or KINS more profitable?

Do insiders and institutionals hold more shares of HIT or KINS?

Does the media prefer HIT or KINS?

Do analysts recommend HIT or KINS?

Summary

How does Health In Tech compare to James River Group?

Which has more risk & volatility, JRVR or HIT?

Which has preferable valuation and earnings, JRVR or HIT?

Do analysts recommend JRVR or HIT?

Is JRVR or HIT more profitable?

Does the media favor JRVR or HIT?

Do institutionals & insiders hold more shares of JRVR or HIT?

Summary

How does Health In Tech compare to SelectQuote?

Is SLQT or HIT more profitable?

Does the media favor SLQT or HIT?

Which has stronger valuation and earnings, SLQT or HIT?

Which has more volatility & risk, SLQT or HIT?

Do institutionals & insiders have more ownership in SLQT or HIT?

Do analysts rate SLQT or HIT?

Summary

How does Health In Tech compare to Roadzen?

Is RDZN or HIT more profitable?

Does the media favor RDZN or HIT?

Which has more volatility and risk, RDZN or HIT?

Which has higher valuation & earnings, RDZN or HIT?

Do institutionals & insiders hold more shares of RDZN or HIT?

Do analysts prefer RDZN or HIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools